Launched nationwide by Novartis, Pluvicto intravenously delivers radioactive doses to prostate cancer cells—a huge step in ...

The NHS will not be automatically inviting all men above a certain age to check for prostate cancer, unlike the approach for some other cancers. The UK National Screening Committee has suggested that ...

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.

A recent breakthrough study highlights how a simple at-home urine test could accurately detect prostate cancer. Researchers from Vanderbilt University and the University of Michigan suggest this ...

A University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their metabolism to thrive in bone tissue, offering a potential new treatment target for patients with ...

Scientists have uncovered new genetic clues that explain why some prostate cancers remain slow-growing while others become life-threatening. Scientists from UCLA, the University of Toronto and the ...

Today, a patient diagnosed with advanced prostate cancer has options. Doctors can offer a suite of androgen-suppressing drugs to extend his life. There are genetic tests that can show whether he’s a ...

When it comes to lung cancer, we know of more than 30 substances that are carcinogenic. But when researchers began investigating why there is a higher incidence of prostate cancer in firefighters, ...